RYZODEG PENFIL

Ryzodeg Penfil is a modern insulin combination therapy designed for comprehensive diabetes management. This pre-filled pen delivers a dual-action formulation combining insulin degludec and insulin aspart, providing both basal and mealtime glucose control in a single injection. The convenient pen format ensures precise dosing and improved patient compliance. Ideal for individuals requiring flexible insulin regimens, Ryzodeg Penfil offers predictable pharmacokinetics with a long duration of action, helping maintain stable blood sugar levels throughout the day and reducing the frequency of injections.